Precise Health Gets a CHF 900’000 Innosuisse Grant
Summary
Precise Health secured a CHF 900,000 Innosuisse grant to develop PhageMatch™, its AI-powered platform for matching bacteriophages to resistant infections. The project involves the University of Geneva and Geneva University Hospitals and aims to shorten the time needed to identify suitable phages. The company wants to combine rapid bacterial characterization with AI-driven matching so clinicians can respond faster to acute and sub-acute AMR cases. If no existing phage fits, the platform can also help design new phages digitally. The work strengthens Precise Health’s software-driven approach to life sciences and clinical decision support.
Funding
Amount
$1.1M
Total raised
Date
June 15, 2026
Announcement date
Investors
-
Lead investors
Company
https://precisehealth.io
Funded company
Classifications
industries
Pharmaceuticals and Chemical
applications
Web and Content Management
AskAI Classifications
Labels
Healthcare Software
Bioinformatics Software
AI/ML Platform
Linked Companies
Precise Health
up to $1M